LGK974   Click here for help

GtoPdb Ligand ID: 11167

Synonyms: LGK-974 | WNT-974 | WNT974
PDB Ligand
Compound class: Synthetic organic
Comment: LGK974 is a clinical stage porcupine inhibitor [2]. It is being developed as an oncology therapeutic [1]. It is the first porcupine inhibitor to advance to clinical trial.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 93.55
Molecular weight 396.17
XLogP 1.87
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(Nc1ccc(cn1)c1cnccn1)Cc1cnc(c(c1)C)c1ccnc(c1)C
Isomeric SMILES O=C(Nc1ccc(cn1)c1cnccn1)Cc1cnc(c(c1)C)c1ccnc(c1)C
InChI InChI=1S/C23H20N6O/c1-15-9-17(12-28-23(15)18-5-6-25-16(2)10-18)11-22(30)29-21-4-3-19(13-27-21)20-14-24-7-8-26-20/h3-10,12-14H,11H2,1-2H3,(H,27,29,30)
InChI Key XXYGTCZJJLTAGH-UHFFFAOYSA-N
References
1. Li J, Wu G, Xu Y, Li J, Ruan N, Chen Y, Zhang Q, Xia Q. (2020)
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
Biomed Res Int, 2020: 2527643. DOI: 10.1155/2020/2527643 [PMID:32104684]
2. Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T, Kasibhatla S, Schuller AG, Li AG, Cheng D et al.. (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Proc Natl Acad Sci USA, 110 (50): 20224-9. [PMID:24277854]